NCT06499896
- Conditions
- Immune-mediated Colitis (IMC), Immune-related Dermatitis
- Locations
-
- UPMC Hillman Cancer Center Pittsburgh, Pennsylvania, United States
Clinical trial condition
Immune-related Dermatitis
Explore clinical trials studying Immune-related Dermatitis. Study availability and eligibility vary by location and protocol.
2 public trials
1 recruiting study
Immune-related Dermatitis trial results
Not Yet Recruiting
An Open-label, Single Center Study Evaluating the Safety and Efficacy of Roflumilast Foam 0.3% in Subjects With Cutaneous Adverse Events Due to Checkpoint Inhibitors
NCT07639840
- Conditions
- Immune-related Dermatitis
- Locations
-
Not specified